Financial health
- Operating income covered interest expense -134.9× in the latest year, down from -17.7× 2 years ago.
JUNS Financials JUPITER NEUROSCIENCES, INC.
3 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $21796 | -$9M | 80.6% | -40873.2% | — | — | — |
| 2024 | — | -$2M | — | — | — | — | — |
| 2023 | — | -$5M | — | — | — | — | — |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $18652 | -$2M | 76.6% | -10524.3% | — | — | — |
| Dec '25 | — | -$3M | — | — | — | — | — |
| Sep '25 | — | -$2M | — | — | — | — | — |
| Jun '25 | — | -$2M | — | — | — | — | — |
| Mar '25 | — | -$2M | — | — | — | — | — |
| Dec '24 | — | -$2M | — | — | — | — | — |
| Sep '24 | — | -$591021 | — | — | — | — | — |
| Jun '24 | — | $313123 | — | — | — | — | — |
| Mar '24 | — | -$634100 | — | — | — | — | — |
| Dec '23 | — | -$429645 | — | — | — | — | — |
| Sep '23 | — | -$2M | — | — | — | — | — |
| Jun '23 | — | -$832605 | — | — | — | — | — |
| Mar '23 | — | -$2M | — | — | — | — | — |
Valuation over time
How the market has priced JUNS against its own fundamentals since 2024-12 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-sales ratio has fallen from 1651.9× (Dec '25) to 396.2× (Jun '26).
P/S
Frequently asked questions
Is JUNS growing its revenue and profit?
See the revenue and net-income charts above for JUPITER NEUROSCIENCES, INC.'s multi-year trend.
How much debt does JUNS have?
As of FY2025, JUPITER NEUROSCIENCES, INC. reported — of total debt against — of cash; operating income covered interest expense -134.9×.
What is JUNS's profit margin?
In FY2025, gross margin was 80.6%, operating margin -40873.2%, and net margin -39662.8%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.